67.48
price down icon6.49%   -4.68
after-market After Hours: 68.05 0.57 +0.84%
loading

Soleno Therapeutics Inc Stock (SLNO) Forecast

The Soleno Therapeutics Inc (SLNO) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $44.16, representing a -34.56% decrease from the current price of $67.48. The highest analyst price target is $66.80, and the lowest is $21.51.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month SLNO Price Target
Average 53.18 (-21.19% Downside)
loading

Is Soleno Therapeutics Inc (SLNO) A Buy Now?

Oscillators
Name Value Action
RSI(14) 65.44 Neutral
STOCH(9,6) 88.04 Sell
STOCHRSI(14) 38.37 Neutral
MACD(12,26) 6.2846 Buy
ADX(14) 34.72 Buy
William %R -24.36 Neutral
CCI(14) 71.44 Neutral
Buy: 2 Sell: 1 Neutral: 4
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
64.16
Buy
65.06
Buy
MA20
56.06
Buy
59.36
Buy
MA50
51.17
Buy
53.45
Buy
MA100
50.22
Buy
51.22
Buy
MA200
49.54
Buy
49.19
Buy
Buy: 10 Sell: 0 Neutral: 0
Summary: Buy
According to our latest analysis, SLNO could be considered a Strong Buy, with 17 technical analysis indicators signaling 12 Buy signals, 1 signaling Sell signals and 4 Neutral signals. This might be a good time to open fresh positions on SLNO, as trading bullish markets is always a lot easier
  1. RSI (Relative Strength Index): The RSI(14) value of 65.44 indicates that SLNO is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 88.04 indicates that SLNO is oversold. This means that SLNO price is at or near the highest level over a specified lookback period.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 38.37 indicates that SLNO is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 34.72 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 71.44 indicates that SLNO is still overbought but not to an extreme extent.

Long-term SLNO price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Soleno Therapeutics Inc financial reports and earnings history, Soleno Therapeutics Inc (SLNO) stock could reach $79.20 by 2030, $77.82 by 2040 and $117.51 by 2050. See the projected annual prices until 2050 of the Soleno Therapeutics Inc stock below:

  • Soleno Therapeutics Inc (SLNO) is expected to reach an average price of $80.21 in 2035, with a high prediction of $80.54 and a low estimate of $72.51. This indicates an $18.86% rise from the last recorded price of $67.48.
  • Soleno Therapeutics Inc (SLNO) stock is projected to chart a bullish course in 2040, with an average price target of $77.07, representing an $14.21% surge from its current level. The forecast ranges from a conservative $75.51 to a sky-high $77.82.
  • Our analysts predict Soleno Therapeutics Inc (SLNO) to jump 41.59% by 2045, soaring from $95.41 to an average price of $95.55, potentially reaching $96.02. While $95.41 is the low estimate, the potential upside is significant.
  • Soleno Therapeutics Inc (SLNO) stock is expected to climb by 2050, reaching an average of $116.79, a $73.07% jump from its current level. However, a wide range of estimates exists, with high and low targets of $117.51 and $116.04, respectively, highlighting the market's uncertainty.

Soleno Therapeutics Inc Stock (SLNO) Year by Year Forecast

Soleno Therapeutics Inc Stock (SLNO) Price Forecast for 2025

Soleno Therapeutics Inc Stock (SLNO) is expected to reach an average price of $52.92 in 2025, with a high prediction of $84.84 and a low estimate of $21.01. This indicates an -21.57% fall from the last recorded price of $67.48.
Month Average Low High Change from today's price
May, 2025 $59.70 $21.51 $66.80 -11.52%
June, 2025 $68.61 $59.99 $78.32 +1.67%
July, 2025 $47.92 $42.34 $84.84 -28.99%
August, 2025 $49.25 $45.85 $53.57 -27.01%
September, 2025 $46.23 $44.10 $49.88 -31.49%
October, 2025 $50.14 $45.96 $52.21 -25.69%
November, 2025 $57.32 $46.19 $64.67 -15.05%
December, 2025 $45.93 $42.33 $54.05 -31.93%

Soleno Therapeutics Inc Stock (SLNO) Price Forecast for 2026

The predicted value for Soleno Therapeutics Inc (SLNO) in 2026 is set at an average of $52.02. Estimates vary from a peak of $70.75 to a trough of $33.29, indicating an -22.91% surge from the present price of $67.48.
Month Average Low High Change from today's price
January, 2026 $48.76 $45.22 $51.55 -27.74%
February, 2026 $50.99 $46.31 $50.99 -24.43%
March, 2026 $51.57 $47.91 $54.89 -23.57%
April, 2026 $65.84 $48.94 $70.75 -2.44%
May, 2026 $44.36 $40.73 $66.31 -34.26%
June, 2026 $38.79 $37.80 $44.85 -42.51%
July, 2026 $35.37 $34.76 $40.24 -47.58%
August, 2026 $38.19 $35.13 $45.95 -43.41%
September, 2026 $36.70 $36.10 $39.48 -45.62%
October, 2026 $35.63 $34.55 $37.03 -47.20%
November, 2026 $35.07 $33.29 $35.94 -48.03%
December, 2026 $35.39 $34.02 $36.07 -47.56%

Soleno Therapeutics Inc Stock (SLNO) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Soleno Therapeutics Inc (SLNO) is $30.00, with a high forecast of $35.33 and a low forecast of $24.67. This indicates an -55.54% decrease from the last price of $67.48.
Month Average Low High Change from today's price
January, 2027 $33.27 $32.93 $35.33 -50.69%
February, 2027 $32.74 $32.44 $34.26 -51.48%
March, 2027 $30.14 $29.47 $32.98 -55.34%
April, 2027 $28.37 $28.02 $30.52 -57.96%
May, 2027 $27.35 $26.22 $29.15 -59.47%
June, 2027 $27.03 $26.80 $28.56 -59.95%
July, 2027 $25.84 $25.49 $27.56 -61.71%
August, 2027 $25.72 $25.53 $26.16 -61.88%
September, 2027 $25.31 $24.67 $26.19 -62.49%
October, 2027 $25.25 $25.13 $26.38 -62.59%
November, 2027 $26.26 $25.31 $26.49 -61.08%
December, 2027 $26.06 $25.57 $27.26 -61.38%

Soleno Therapeutics Inc Stock (SLNO) Price Forecast for 2028

In 2028, Soleno Therapeutics Inc (SLNO) is projected to reach an average price of $27.79, with a high projection of $30.99 and a low estimate of $24.59. This indicates an -58.81% fall from the last price of $67.48.
Month Average Low High Change from today's price
January, 2028 $25.42 $25.15 $26.23 -62.32%
February, 2028 $25.13 $25.06 $25.82 -62.75%
March, 2028 $24.62 $24.61 $25.33 -63.52%
April, 2028 $24.84 $24.59 $25.15 -63.20%
May, 2028 $25.41 $24.74 $26.34 -62.35%
June, 2028 $26.52 $25.39 $26.75 -60.70%
July, 2028 $26.32 $26.09 $27.24 -61.00%
August, 2028 $26.47 $26.05 $26.79 -60.77%
September, 2028 $26.91 $26.31 $27.24 -60.12%
October, 2028 $28.48 $26.84 $28.71 -57.80%
November, 2028 $30.71 $28.43 $30.86 -54.49%
December, 2028 $29.18 $28.75 $30.99 -56.76%

Soleno Therapeutics Inc Stock (SLNO) Price Forecast for 2029

The 2029 price forecast for Soleno Therapeutics Inc Stock (SLNO) is $54.63 on average, with a high prediction of $80.31 and a low estimate of $28.94. This represents an -19.05% decrease from the previous price of $67.48.
Month Average Low High Change from today's price
January, 2029 $30.15 $28.94 $30.47 -55.32%
February, 2029 $30.22 $29.28 $30.60 -55.21%
March, 2029 $30.21 $28.97 $30.82 -55.23%
April, 2029 $49.69 $29.30 $55.68 -26.36%
May, 2029 $47.60 $46.90 $51.21 -29.46%
June, 2029 $55.56 $47.03 $56.15 -17.66%
July, 2029 $66.11 $53.04 $66.60 -2.03%
August, 2029 $72.37 $61.60 $74.87 +7.25%
September, 2029 $75.15 $71.39 $76.68 +11.37%
October, 2029 $68.33 $63.99 $80.01 +1.25%
November, 2029 $63.95 $63.06 $70.52 -5.24%
December, 2029 $64.59 $63.57 $80.31 -4.29%

Soleno Therapeutics Inc Stock (SLNO) Price Forecast for 2030

Soleno Therapeutics Inc Stock (SLNO) is expected to reach an average price of $68.68 in 2030, with a high forecast of $98.08 and a low forecast of $39.29. This signifies an +1.78% surge from the last price of $67.48.
Month Average Low High Change from today's price
January, 2030 $75.37 $61.91 $79.20 +11.69%
February, 2030 $77.43 $71.98 $81.03 +14.74%
March, 2030 $66.29 $64.04 $80.34 -1.77%
April, 2030 $62.05 $60.57 $66.35 -8.05%
May, 2030 $58.02 $56.97 $63.89 -14.02%
June, 2030 $56.03 $53.48 $63.93 -16.97%
July, 2030 $59.35 $56.24 $60.57 -12.04%
August, 2030 $62.31 $58.67 $68.55 -7.66%
September, 2030 $82.37 $39.29 $98.08 +22.07%
October, 2030 $80.36 $39.56 $97.48 +19.09%
November, 2030 $69.45 $39.86 $88.14 +2.93%
December, 2030 $71.06 $56.77 $77.51 +5.31%
$60.58
price down icon 3.01%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
Cap:     |  Volume (24h):